Skip to content

The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

The Outcomes of Arteriovenous Fistula (AVF) Cannulated From Different Direction in Maintenance Hemodialysis Patients.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01642459
Enrollment
10
Registered
2012-07-17
Start date
2012-09-30
Completion date
2013-04-30
Last updated
2015-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Fistula

Keywords

arteriovenous fistula, hemodialysis, aneurysm, vascular stenosis, cannulation

Brief summary

The investigators hypothesis that aneurysms and stenoses will be decreased if the direction of inserted arterial needle were same as the direction of blood flow, when compared to the opposite direction puncture.

Detailed description

Native arteriovenous fistula (AVF) is the preferred access for hemodialysis, and cannulation technique is very important factors affect the outcomes of AVF. Rope-ladder cannulation is one kind of the standard puncture techniques which is used commonly in maintenance hemodialysis (MHD) patients. There are many complications for rope-ladder cannulation, such as venous aneurysm and vascular stenosis, which may induce AVF dysfunction. For the venous outflow way, there always be aneurysm followed by stenoses at the sites of needle connected with the arterial line in rope-ladder cannulation patients. The investigators hypothesis that the directions of inserted arterial needles should affect the AVF outcomes. The present prospective study will compare the outcomes of AVF between the puncture direction at arterial needle sites same as blood flow and opposite to blood flow.

Interventions

OTHERSame direction cannulation

The puncture direction of the arterial needle is same as the blood flow in every hemodialysis session.

OTHEROpposite direction cannulation

The puncture direction of the arterial needle is opposite to the blood flow in every hemodialysis session.

Sponsors

Dongliang Zhang, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* MHD patients with autogenous AVF. * Newly setup AVF in 3 months. * Fore- or Upper arm AVF. * Flow of \>800ml/min detected by using the ultrasound dilution technique.

Exclusion criteria

* AVF after neoplasty. * Arteriovenous grafts. * Anticipated live time less than one year. * Patients whose concurrent illnesses, disability, or geographical residence would hamper attendance at required study visit.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of AVF aneurysm and stenosis.12 monthsCompare the prevalence of AVF aneurysm and stenosis between two groups during 12 months.

Secondary

MeasureTime frameDescription
Proportions of AVF dysfunction in different groups.12 monthsCompare the proportions of AVF dysfunction between two groups during 12 months.
The size of venous aneurysm.12 monthsMeasure the maximum size of venous aneurysm by using ultrasonography at month 12.
Diameter of venous stenosis.12 monthsMeasure the minimum diameter of venous stenosis by ultrasonography at month 12.
Percentages of unsuccessful cannulations.12 monthsUnsuccessful cannulations include mis-cannulation, cannulation ease, hematoma, more than once cannulation at arterial site.
Events of AVF obstruction.12 monthsAVF obstruction and the following treatments as central venous catheters and interventions will be recorded and compared between two groups during 12 months.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026